跳至主要内容
临床试验/DRKS00022381
DRKS00022381尚未招募不适用

Observational post-market surveillance registry including subjects treated with biodegradable magnesium-based implants specific for the intended use

Syntellix AG0 个研究点目标入组 1,000 人开始时间: 2020年7月7日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
Syntellix AG
入组人数
1,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Indication for treatment with MAGNEZIX® product according to the IFU.
  • - Age = 18 years.
  • - Written informed consent for all individual patient data entered into the database.

排除标准

  • - Exclusion according to the IFU.
  • - Known allergies against any components of the implant.
  • - Participation in an interventional orthopedic or surgical trial prior to surgery.

研究者

发起方
Syntellix AG

相似试验